Qvt Financial LP Intercept Pharmaceuticals, Inc. Transaction History

Qvt Financial LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$46.7 - $92.04 $175,732 - $346,346	-3,763 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$91.83 - $120.68 $183,660 - $241,360	-2,000 Reduced 34.7%	3,763 $421,000
Q2 2018 Aug 14, 2018	SELL	$60.0 - $85.67 $329,460 - $470,413	-5,491 Reduced 48.79%	5,763 $484,000
Q1 2018 May 15, 2018	SELL	$52.72 - $67.25 $137,072 - $174,850	-2,600 Reduced 18.77%	11,254 $692,000
Q4 2017 Feb 14, 2018	SELL	$58.2 - $72.76 $407,400 - $509,320	-7,000 Reduced 33.57%	13,854 $809,000
Q3 2017 Nov 14, 2017	BUY	$57.01 - $118.75 $1.19 Million - $2.48 Million	20,854	20,854 $1.21 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Qvt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Qvt Financial LP with notifications on news.